Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
17:37:28 EDT Sun 05 May 2024
Enter Symbol
or Name
USA
CA



News for U:LIFE from 2023-05-04 to 2024-05-03 - 22 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-05-02 16:00U:LIFENews ReleaseaTyr Pharma Announces First Quarter 2024 Results and Provides Corporate Update
2024-04-01 08:00U:LIFENews ReleaseaTyr Pharma to Participate in April Investor Conferences
2024-03-14 16:00U:LIFENews ReleaseaTyr Pharma Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Update
2024-02-28 08:00U:LIFENews ReleaseaTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2023 Financial Results
2024-02-21 08:00U:LIFENews ReleaseaTyr Pharma Announces Expanded Access Program (EAP) for EFZO-FIT ¢ „ ¢ Clinical Trial Participants
2024-01-29 08:00U:LIFENews ReleaseaTyr Pharma to Present Posters Highlighting Importance of Neuropilin-2 in Immune Regulation at Keystone Symposia on Myeloid Cell Diversity
2024-01-18 08:00U:LIFENews ReleaseaTyr Pharma Announces Howard University President Emeritus Dr. Wayne A. I. Frederick as Advisor
2023-11-13 08:00U:LIFENews ReleaseaTyr Pharma Presents Poster Demonstrating Preclinical Effects of Efzofitimod in Rheumatoid Arthritis and Rheumatoid Arthritis-Associated ILD at the ACR Convergence 2023
2023-11-09 16:00U:LIFENews ReleaseaTyr Pharma Announces Third Quarter 2023 Results and Provides Corporate Update
2023-11-01 08:00U:LIFENews ReleaseaTyr Pharma to Present at November Investor Conferences
2023-10-31 08:00U:LIFENews ReleaseaTyr Pharma Announces Dosing of First Patient in Phase 2 EFZO-CONNECT ¢ „ ¢ Study of Efzofitimod in Patients with SSc-ILD
2023-09-11 08:00U:LIFENews ReleaseaTyr Pharma Presents Efzofitimod Data Demonstrating Statistically Significant Improvements in Time to Relapse, FVC and Patient Reported Outcomes
2023-08-24 08:00U:LIFENews ReleaseaTyr Pharma to Present at the H.C. Wainwright 25th Annual Global Investment Conference
2023-08-09 16:00U:LIFENews ReleaseaTyr Pharma Announces Second Quarter 2023 Results and Provides Corporate Update
2023-06-22 08:00U:LIFENews ReleaseEuropean Commission Grants Orphan Drug Designation for aTyr Pharma ¢ € ™s Efzofitimod for Treatment of Systemic Sclerosis
2023-06-20 08:00U:LIFENews ReleaseaTyr Pharma to Present on Lead Therapeutic Candidate Efzofitimod at the World Association for Sarcoidosis and Other Granulomatous Disorders (WASOG) Conference
2023-06-09 16:00U:LIFENews ReleaseaTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2023-06-06 08:00U:LIFENews ReleaseaTyr Pharma to Highlight Advancements in tRNA Synthetase Biology Research at the 13th International Symposium of Aminoacyl-tRNA Synthetases (AARS 2023)
2023-05-25 08:00U:LIFENews ReleaseaTyr Pharma to Present at the 2023 Jefferies Healthcare Conference
2023-05-22 08:00U:LIFENews ReleaseaTyr Pharma Presents New Data on Efzofitimod Mechanism of Action and Positive Exposure-Response at the American Thoracic Society 2023 International Conference
2023-05-11 16:00U:LIFENews ReleaseaTyr Pharma to Present at the 2023 RBC Capital Markets Global Healthcare Conference
2023-05-09 16:00U:LIFENews ReleaseaTyr Pharma Announces First Quarter 2023 Results and Provides Corporate Update